Payer: Page


  • Image attribution tooltip
    UnitedHealth Group
    Image attribution tooltip

    UnitedHealth reports nearly $14B in 2019 profit

    The company beat forecasts on Q4 earnings, though revenues of $60.9 billion were slightly lower than Wall Street expectations.

    By Jan. 15, 2020
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    LabCorp, Quest push for M&A-driven growth despite difficulties closing deals

    "It’s still a very fragmented marketplace. There’s plenty of opportunity for us to consolidate it," Quest CEO Steve Rusckowski said.

    By Nick Paul Taylor • Jan. 15, 2020
  • Explore the Trendline
    Image attribution tooltip
    Yujin Kim/Healthcare Dive
    Image attribution tooltip
    Trendline

    Payer/provider relationships

    As M&A intensifies and companies embrace more holistic and value-based care models, partnerships have become more closely intertwined.

    By Healthcare Dive staff
  • Deep Dive

    Will more employers get off the healthcare bench in 2020?

    "At the end of the day, employers have to put their hands on the steering wheel as purchasers of healthcare," Suzanne Delbanco, executive director of Catalyst for Payment Reform, said.

    By Jan. 14, 2020
  • Cigna links up with upstart Oscar for small business health insurance

    New York City-based Oscar has won some praise for customer service, but also criticism for small provider networks.

    By Jan. 14, 2020
  • JPM20: Rivals Molina, Centene pitch investors on organic growth

    "I'll repeat this countless numbers of times this afternoon: Our first priority is to grow the business organically. It is the most efficient use of capital," Molina CEO Joseph Zubretsky said as the annual investor conference kicked off.

    By Jan. 14, 2020
  • Supreme Court to take on PBM rate regulation

    A federal appeals court previously ruled in favor of pharmacy benefit managers, finding federal law preempts states from regulating their rates.

    By Jan. 13, 2020
  • The government recovered $3B in fraud last year. Nearly 90% was from healthcare

    It marks the 10th consecutive year the DOJ has recouped more than $2 billion from False Claims Act settlements and judgments for HHS.

    By Jan. 10, 2020
  • CVS, Mayo, Tenet among healthcare companies to watch at #JPM20

    As many as 9,000 attendees across 450 public and private companies are expected to make an appearance in San Francisco at one of the most influential conferences of the year.

    By , , Jan. 10, 2020
  • Individual market appears stable despite lack of mandate penalty

    Claims costs in the first nine months of 2019 grew and average hospital time dipped, indicating the market didn't have disproportionately sicker patients, according to the Kaiser Family Foundation.

    By Jan. 8, 2020
  • Molina expands Illinois footprint with $50M acquisition

    The buy of NextLevel Health Partners, if approved, would give Molina more members in Cook County.

    By Jan. 8, 2020
  • Image attribution tooltip
    Fotolia
    Image attribution tooltip

    DOJ joins whistleblower suit against Indiana system for alleged Stark violation

    Community Health Network is accused of submitting as many as hundreds of thousands of fraudulent claims to Medicare and other federal programs from at least 2008 to 2017.

    By Jan. 8, 2020
  • CMS proposes using more encounter data for MA risk adjustment

    The mix of encounter data used to calculate payments would go up to 75% next year under the proposed regulation. Payers have railed against previous increases, saying the information is inaccurate and unreliable.

    By Jan. 7, 2020
  • Ex-Anthem exec Brad Smith appointed head of CMS innovation center

    Smith, previously co-founder and CEO of palliative care company Aspire Health, replaces outgoing CMMI head Adam Boehler.

    By Jan. 7, 2020
  • Image attribution tooltip
    Alex Hickey
    Image attribution tooltip

    Supreme Court says ACA opponents have until Friday to respond to motion to expedite

    The court set the deadline Monday after a push by the law's supporters to have the case heard before this year's presidential election.

    By Updated Jan. 7, 2020
  • Image attribution tooltip
    Dollar Photo Club
    Image attribution tooltip

    In win for big payers, appeals court sides with HHS in risk adjustment case

    AHIP and the Blues argued it would be inconceivable to come up with an entirely new formula for the payments created under the Affordable Care Act.

    By Jan. 3, 2020
  • Pfizer, AbbVie and Gilead among drugmakers boosting prices to start 2020

    List prices rose on some of the top-selling medicines in the U.S., including Humira, Opdivo, Prevnar 13 and Biktarvy.

    By Andrew Dunn • Jan. 2, 2020
  • ACA 2020 enrollment stable but dips slightly

    CMS attributed the decline to a few factors, including a strong economy that may have moved more people into job-based coverage and states expanding Medicaid eligibility.

    By Ron Shinkman • Dec. 23, 2019
  • Image attribution tooltip
    Brian Tucker Industry Dive Image | courtesy of California Office of Attorney General
    Image attribution tooltip

    Sutter to pay $575M, change contracting practices in antitrust settlement

    Pending approval, the deal bars the dominant Northern California system from using all-or-nothing contracts and stops certain bundling practices.

    By Dec. 20, 2019
  • MA value-based plan enrollment tripling for 2020

    CMS also moved to fold hospice care into Medicare Advantage, a cost-cutting step industry has expected for a while.

    By Dec. 20, 2019
  • With ACA ruling, payers get unexpected short-term reprieve

    Analysts say Wednesday's appeals court decision finding the Affordable Care Act's individual mandate unconstitutional is not the worst thing that could have happened for payers — for now.

    By Dec. 19, 2019
  • Trump administration lays out plans to import drugs from abroad

    But it's not clear how effective importation would be at achieving the administration's goal of reducing drug prices. High-cost drugs like biologics, for example, are excluded from one of the two proposals.

    By Ned Pagliarulo • Dec. 18, 2019
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Providers push back on PhRMA report highlighting 340B program costs

    American Hospital Association executive vice president Tom Nickels blasted a new drugmaker-funded study as an "obvious attempt to divert attention away from a problem of their own making: skyrocketing drug prices."

    By Dec. 18, 2019
  • Image attribution tooltip
    Dollar Photo Club
    Image attribution tooltip

    Judge refuses to strike down 2020 site-neutral plan — but chides CMS

    The federal judge said she lacks jurisdiction to strike down a policy yet to go into effect, but noted the agency's plans for next year disregard her earlier ruling.

    By Dec. 17, 2019
  • A picture of the exterior of a CVS Pharmacy with the logo and name in view.
    Image attribution tooltip
    Bruce Bennett via Getty Images
    Image attribution tooltip

    CVS long-term care pharmacy sued by DOJ over fraudulent prescribing practices

    The suit is by no means the first time the subsidiary, acquired in 2015 for about $12.7 billion, has been under the federal microscope for fraud.

    By Dec. 17, 2019
  • CMS wants to overhaul how organs are procured in the US

    The agency estimates if all procurement groups met both the new donation and transplantation rate measures, the number of yearly transplants would shoot up more than 15% by 2026.

    By Dec. 17, 2019